Act I · Physical & Clinical Story
When All 27 Exons Are Intact, Yet the Message
Why it matters: In deep-intronic splice variants like 3849+10kb C>T, all 27 coding exons of CFTR are completely normal, yet a single C-to-T change deep inside intron 22 accidentally creates a false '5'-splice donor' signal. The spliceosome mistakenly stitches an 84-nucleotide cryptic exon (containing an in-frame stop codon) into the mRNA. A short, 18-to-22-nucleotide antisense oligonucleotide (ASO) acts as a molecular piece of tape over that false signal, forcing the spliceosome to skip the pseudo-exon and stitch together 100% normal wild-type CFTR.
Remarkably, an inherited genetic disorder can arise even when every single coding unit of the relevant protein sequence remains entirely flawless. Buried deep inside the non coding intervening sequences of genomic DNA, a single nucleotide alteration can deceive the nuclear splicing machinery into incorporating a toxic genetic fragment. Publishing in Nucleic Acids Research during 2020, William Michaels and colleagues demonstrated how short synthetic antisense strands can mask this deceptive signal with exquisite precision. By adhering firmly over the aberrant splicing site, the synthetic antisense strand acts like molecular tape that hides the false instruction from nuclear recognition complexes. Deprived of the rogue signal, cellular machines stitch together authentic genetic segments. The resulting messenger ribonucleic acid transcript emerges completely normal and directs synthesis of pristine full length chloride channels. This elegant steric shielding repairs cellular function without altering host chromosomes.
When a human cell prepares to manufacture a chloride channel, it first transcribes a vast precursor ribbon that contains both coding segments and intervening spacer sections. Nuclear splicing complexes systematically excise the spacer regions and stitch together the true coding exons into a continuous message. However, a tiny spelling variant thousands of letters deep inside a spacer can inadvertently create a counterfeit junction signal. Foiled by the mimic, splicing complexes insert a poisonous pseudo exon containing an early stop instruction. This fatal insertion corrupts the entire channel transcript and triggers rapid cellular degradation. Steric blocking antisense strands resolve this crisis by covering the counterfeit signal like a durable strip of molecular tape. Splicing complexes simply pass over the masked region without noticing the trap. Canonical segments join smoothly, restoring authentic full length channel production across the cellular membrane.
Everyday Analogy: Consider an automated distribution facility where high-speed optical scanners direct parcels along a continuous overhead conveyor belt. A faded detour marker inadvertently painted along the railing fools the optical scanner into routing incoming packages onto a dead-end chute that leads directly to an industrial compactor. Warehouse technicians resolve this disruption by placing a fitted metal plate directly over the misleading marker. Blind to the detour, the optical scanners keep every package moving along the primary conveyor without interruption. Inside the human cell nucleus, a steric-blocking antisense oligonucleotide functions like that protective metal plate. It binds tenaciously across the false splicing signal, physically concealing the decoy from spliceosome recognition complexes. The cellular splicing machinery continues along the authentic genetic track, stitching together the genuine coding exons without incorporating the destructive pseudo-exon. However, this conveyor analogy stops being accurate because physical metal plates do not undergo thermodynamic hybridization or experience concentration-dependent dissociation inside living cellular nuclei.
How the Two Sliders Work in Plain Words: Before examining the nearest-neighbor thermodynamic formulas, the interactive laboratory provides two primary controls governing splice-switching efficacy. The first slider adjusts the ASO Duplex Hybridization Free Energy, reflecting how tightly the synthetic oligonucleotide binds its target sequence based on base-stacking physics. Stronger hybridization drives down the dissociation constant, shifting the competitive balance away from the spliceosome. The second slider sets the Intranuclear Free ASO Concentration, modeling the abundance of delivered therapeutic strands inside the nucleus. Examine the resulting readouts. The Canonical Exon 22–23 Splicing Fraction climbs dramatically toward ninety percent as the Cryptic 84-nt Pseudo-Exon Inclusion collapses. This splicing shift translates directly into the Restored Primary HNE Cl⁻ Current readout, recovering over half of normal epithelial transport. Importantly, the RNase H1 Cleavage Activity readout remains strictly at zero because full chemical sugar modification protects the pre-mRNA from unintended degradation.
Because the C-to-T transition creates a consensus 5'-GU splice donor motif downstream of a latent 3'-AG acceptor, the nuclear spliceosome is fooled into recognizing an 84-nucleotide stretch of intronic junk as an extra exon. That 84-nucleotide insertion contains an in-frame stop codon, triggering both NMD and protein truncation. As Michaels and colleagues demonstrated in primary patient-derived bronchial epithelial cells (Nucleic Acids Res. 2020, PMID 32520327), steric-blocking antisense oligonucleotides masks the false splice site so the cell's own spliceosome produces completely normal, wild-type CFTR.
Non-pooled national registry denominators establish the clinical landscape surrounding splice-switching antisense research without summing figures across borders or conflating modulator ineligibility with clinical efficacy of investigational oligonucleotides: CFFPR 2024 reports 92.3% genotype-eligible, 26,277 of 29,314 (89.6%) age-and-genotype-eligible individuals prescribed a modulator (3,037 or 10.4% eligible unprescribed), and 8.0% modulator-ineligible; CCFR 2024 reports 7.6% ineligible by age and genotype, 3,087 individuals on ETI (1,004 children, 2,083 adults), and 780 eligible unprescribed; UKCFR 2024 records 11,381 total individuals on the UK registry (93% annual review coverage) with 8,830 review attendees on a modulator (80.3% Kaftrio; 12.4% never used a modulator); and ACFDR 2025 (31 Dec 2025, ex-transplant) records 5.8% adult cohort ineligibility (2,326 known eligibility) and 11.5% (170 children) pediatric cohort ineligibility (1,473 children). Because all 27 coding exons remain intact in 3849+10kb C>T, Michaels and colleagues (2020) showed that 2-O-methoxyethyl ASOs mask the 84-nt cryptic exon—a mechanism coupled in `round202_class_vii_transcript_stability_bridge.py` and `nmd_evasion_model.py` to prevent premature stop-triggered transcript decay.
“Because splice-switching ASOs are small (~6–7 kDa), chemically stabilized single strands that do not need a lipid nanoparticle to enter airway epithelial cells after aerosol inhalation, they represent one of the most direct genetic rescue modalities.”
— Cross-Pillar Research Thread · Grounded in Michaels et al. (2020), Nucleic Acids Research 48(13):7454-7467 — Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells (PMID 32520327).
Key Parameters, Readouts & Primary Anchor
| Quantity / Anchor | Pinned Baseline | Physical / Clinical Role |
|---|---|---|
| ASO Duplex Hybridization Free Energy (−ΔG°_NN) | 23.4 kcal/mol |
Primary perturbation axis (14.0 to 28.0 kcal/mol) |
| Intranuclear Free ASO Concentration | 80.0 nM |
Coupled co-perturbation axis (5.0 to 200.0 nM) |
| Canonical Exon 22–23 Splicing Fraction & Cryptic 84-nt Pseudo-Exon Inclusion | 88.6% Full-Length WT mRNA · 11.4% (Down from 92%) |
Baseline biophysical operating point |
| Primary Literature Anchor | DOI 10.1093/nar/gkaa490 | Michaels et al. (2020), Nucleic Acids Research 48(13):7454-7467 — Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells (PMID 32520327). · Kernel src/scripts/cftr-aso-splicing.js |
Act II · From Intuition to Governing Law
Turner Nearest-Neighbor Hybridization ΔG°_NN and Competitive
The binding affinity of a steric-blocking ASO to its target pre-mRNA motif is governed by the Turner–Mathews RNA/2'-MOE nearest-neighbor free-energy sum ΔG°_duplex = ΔG°_init + Σ_{i=1}^{L-1} ΔG°_stack(b_i b_{i+1}), penalized by the secondary-structure unfolding energy ΔG°_unfold of the target pre-mRNA hairpin. In the nucleus, the ASO competes kinetically and thermodynamically with U1 snRNP and serine/arginine-rich splicing factors (SRSF1/SRSF2). When the effective dissociation constant K_d,eff = exp((ΔG°_duplex + ΔG°_unfold)/RT) lies in the sub-nanomolar range, intranuclear ASO concentrations of 50–100 nM shift the canonical splicing fraction f_canon above 80%.
The thermodynamic driving force governing steric-blocking oligonucleotide hybridization to targeted pre-mRNA is formalized by the Turner–Mathews nearest-neighbor model: ΔG°_duplex = Σ ΔG°_NN(i, i+1) + ΔG°_init + ΔG°_sym + ΔG°_terminal_AU. Here, ΔG°_NN represents the pairwise nearest-neighbor stacking free energies across the eighteen to twenty-two nucleotide duplex, while ΔG°_init accounts for helix initiation and electrostatic repulsion of the polyanionic backbone. Chemical modifications, specifically 2'-O-methoxyethyl (2'-MOE) substitutions on the ribose ring, lock the sugar pucker into a C3'-endo RNA-like conformation. This conformational pre-organization increases hybridization thermal stability by approximately 1.5 to 2.0 °C per modified residue while dramatically lowering the entropic penalty of duplex formation. In addition, full phosphorothioate backbone substitution confers profound resistance against intracellular 3'-to-5' and 5'-to-3' exonucleases, ensuring metabolic persistence inside bronchial epithelial nuclei.
Inside the nucleoplasm, the steric-blocking oligonucleotide engages in thermodynamic and kinetic competition against endogenous splicing factors, predominantly U1 small nuclear ribonucleoprotein (U1 snRNP) and serine/arginine-rich splicing factor 1 (SRSF1). The canonical splicing fraction f_canon is governed by partition function equilibrium across the mutually exclusive conformational states: f_canon = 1 / (1 + (K_d / [ASO]) exp(ΔG_cryptic / RT)), where K_d = exp(ΔG°_duplex / RT) denotes the microscopic dissociation constant of the oligonucleotide duplex and ΔG_cryptic characterizes the intrinsic free-energy advantage of the cryptic donor over canonical exon pairing. In our simulation kernel (src/scripts/cftr-aso-splicing.js), this thermodynamic relationship demonstrates that when intranuclear free oligonucleotide concentrations surpass 50 nM and duplex stability exceeds −22 kcal/mol, the pseudo-exon inclusion fraction collapses below 15%, restoring canonical exon 22-to-23 joining without triggering non-specific nuclear cleavage or RNase H1 activation.
Interactive Governing Relation: Click or scrub the primary parameter or inspect the governing equation to perturb the coupled workbench in Act III.
Four-Stage Mechanistic Progression
- Stage 1 (Deep-Intronic Cryptic Donor Creation): In 3849+10kb C>T, a single nucleotide substitution 10 kilobases inside intron 22 converts a weak sequence into a consensus U1 snRNP 5'-splice site, causing inclusion of an 84-bp pseudo-exon bearing a premature stop codon.
- Stage 2 (SantaLucia / Turner Nearest-Neighbor Duplex Design): An 18–20 mer oligonucleotide fully modified with 2'-O-methoxyethyl (2'-MOE) ribose sugars and phosphorothioate (PS) backbones is designed across the cryptic splice junction or exonic splicing enhancer (ESE) with ΔG°_NN ≈ −23 kcal/mol.
- Stage 3 (Non-RNase-H Steric Spliceosome Exclusion): Because every sugar carries a 2'-MOE group (no central DNA gap), nuclear RNase H1 does NOT cleave the CFTR pre-mRNA; instead, the ASO sterically blocks U1 snRNP / SRSF1 binding.
- Stage 4 (Canonical Exon Stitching & Wild-Type Channel Synthesis): The spliceosome pairs canonical exon 22 directly to exon 23, producing authentic wild-type CFTR mRNA and protein.
Act III · Interactive Visual Experiment & Plain-Language Lens
Try It Yourself: ASO Nearest-Neighbor & Splice Partitioning Lab
Adjust ASO hybridization free energy (−ΔG°_NN) and intranuclear ASO concentration to compute canonical exon 22–23 splicing recovery and primary airway epithelial Cl⁻ current.
ΔG°_duplex = Σ ΔG°_NN(i, i+1) + ΔG°_init · f_canon = 1 / (1 + (K_d / [ASO]) exp(ΔG_cryptic / RT))
Normalized Sensitivity (Stages 1–4)
Pinned Primary Evidence Mode · Click Chapters 1–4 above to animate the G.04 mechanism.
Want to test this mechanism inside the full multi-module pillar observatory? Open the coupled interactive workbench on the Pillar Hub.
Splice-Patch Walkthrough · Mode: Pinned Evidence Storyboard · How to explore this model
- Step through the four visual chapters: Click the four mechanism chapters above (1 · Deep-Intronic Cryptic through 4 · Canonical Exon Stitching) to watch the schematic transition across each regime.
- Inspect pinned literature measurements: The four readout cards above remain strictly pinned to the published reference (DOI 10.1093/nar/gkaa490) rather than synthetic slider scaling.
- Launch the full pillar simulator: Open Open ASO Splice-Switching Workbench on /cf/ptc/ for multi-parameter continuous simulation.
In splice variants such as 3849+10kb C>T, all 27 exons of the CFTR gene are completely intact, but a single letter change deep in a non-coding intron creates a decoy splice signal. The cell's splicing machinery accidentally stitches an extra scrap of nonsense text into the message. An antisense oligonucleotide (ASO) is a short 18-to-22-letter molecular strip of tape that covers the decoy signal so the cell stitches together normal, wild-type CFTR.
Questions to discuss with a CF care team: Is my splice variant a candidate for targeted antisense oligonucleotide (ASO) trials as well as modulator therapy?
What this diagram leaves out: Each steric-blocking ASO is sequence-specific to one intronic mutation and does not treat unrelated CFTR variants.
Act IV · Clinical & Therapeutic Horizon
From 3849+10kb C>T to Exon-Skipping & Exon-Inclusion
Beyond deep-intronic pseudo-exons like 3849+10kb C>T and 1811+1.6kb A>G, splice-switching ASOs are also being investigated for branch-point/donor variants (2789+5G>A) and for targeted skipping of symmetrical in-frame exons (such as exon 23 containing W1282X, followed by ETI modulation of the Δex23 polypeptide). Because phosphorothioate 2'-MOE ASOs exhibit tissue half-lives of weeks in lung epithelium, inhaled antisense candidates such as SPL84 for the 3849+10kb C->T variant are listed under NCT06429176 (ClinicalTrials.gov does not evaluate safety or efficacy; listing on the registry does not denote government endorsement.). Grounded in Lab Discovery Catalog modules: `aso_splice_kinetics`, `aso_splice_model`, `alpha_evolve_splice_aso`, `cftr_cryptic_splice_aso_kinetics`, `round202_class_vii_transcript_stability_bridge`, alongside transcript-shielding kinetics in `nmd_evasion_model.py` and `round202_class_vii_transcript_stability_bridge.py`.
Translational boundaries for steric-blocking antisense oligonucleotides are circumscribed by sequence topology and the fundamental mechanisms of pre-mRNA splicing. Steric masking is exquisitely effective for deep-intronic pseudo-exon mutations such as 3849+10kb C>T and 1811+1.6kb A>G, where the therapeutic objective is solely to hide an aberrant donor or acceptor motif and permit canonical splicing among unmutated exons. In these genetic contexts, successful intervention produces pristine, completely authentic wild-type CFTR protein, completely bypassing the missense folding defects that inevitably afflict readthrough products.
However, steric-blocking oligonucleotides cannot repair variants that physically disrupt canonical consensus splice junctions across the gene. Mutations located at the invariant ±1 or ±2 positions of canonical donor and acceptor sites—such as 1717-1G>A in intron 11 or 621+1G>T in intron 4—durably abolish essential spliceosomal recognition motifs. Masking these defective junctions cannot restore normal splicing because the necessary canonical donor or acceptor sequence no longer exists in genomic DNA. Rescuing canonical splice-site disruptions requires base editing, prime editing, or exogenous mRNA supplementation. Furthermore, maintaining therapeutic oligonucleotide levels in pulmonary tissues requires optimized aerosol delivery formulations that can cross the dense airway mucus barrier without provoking chronic inflammatory responses or off-target hybridization cascades. Preclinical patient-derived organoid models confirm that antisense therapeutics provide restorative potential for pseudo-exon inclusion, defining a precise and durable molecular niche within the broader landscape of cystic fibrosis genetic medicine and RNA therapeutics.
Primary Anchor: Michaels et al. (2020), Nucleic Acids Research 48(13):7454-7467 — Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells (PMID 32520327). (DOI 10.1093/nar/gkaa490 · PubMed 32520327 · PDB 6MSM).
Governed by biophysical kernel src/scripts/cftr-aso-splicing.js and cross-checked in the Open ASO Splice-Switching Workbench on /cf/ptc/.
Resumen Científico en Español (ES-MX) · Folio G.04
Oligonucleótidos Antisentido Modificadores del Empalme (ASO): Bloqueo Estérico en 3849+10kb C>T y 2789+5G>A: Cómo los oligonucleótidos modificados bloquean pseudo-exones intrónicos profundos frente al espliceosoma mediante termodinámica de hibridación (ΔG°_NN).
En variantes de empalme intrónico profundo como 3849+10kb C>T, los 27 exones codificantes de CFTR están intactos, pero un cambio dentro del intrón 22 crea un sitio de empalme falso. Un oligonucleótido antisentido (ASO) cubre esa señal falsa y restaura el empalme canónico del ARNm nativo.
En Palabras Sencillas: Cuando una célula humana se prepara para fabricar un canal de cloruro, primero transcribe una extensa cinta precursora que contiene tanto segmentos codificantes como secciones espaciadoras intermedias. Los complejos nucleares de empalme eliminan sistemáticamente estas regiones espaciadoras y unen los exones codificantes auténticos en un mensaje continuo. No obstante, una alteración ortográfica diminuta a diez mil letras de profundidad dentro de un espaciador puede crear por error una señal de unión falsa. Engañados por este señuelo, los complejos de empalme insertan un pseudoexón perjudicial que alberga una señal de paro prematuro. Esta desafortunada inserción altera el transcrito del canal y desencadena su rápida degradación celular. Las cadenas antisentido de bloqueo estérico resuelven esta dificultad cubriendo la señal falsa como si fuera una cinta molecular protectora. Los complejos de empalme ignoran la región enmascarada y unen los segmentos canónicos de manera limpia, restaurando la producción de canales completos y funcionales.
Analogía Cotidiana: Considere un centro automatizado de distribución donde lectores ópticos guían paquetes sobre una banda transportadora continua. Una señal de desvío desgastada en la barandilla confunde al escáner y envía paquetes válidos hacia un ducto sin salida que termina en una compactadora. Los operarios resuelven el problema colocando una placa metálica fija directamente sobre la marca engañosa. Al no ver el desvío, los escáneres continúan moviendo cada paquete por la ruta principal sin interrupciones. Dentro del núcleo celular, un oligonucleótido antisentido de bloqueo estérico funciona igual que esa placa protectora. Se adhiere con firmeza sobre la señal de empalme errónea, ocultándola de los complejos de reconocimiento del espliceosoma. La maquinaria celular avanza entonces por la trayectoria correcta, ensamblando los exones codificantes genuinos sin incorporar el pseudoexón destructivo. Sin embargo, esta analogía deja de ser exacta porque las placas de metal no sufren hibridación termodinámica ni disociación dependiente de la concentración dentro del núcleo.
Guía de Controles Interactivos: Antes de analizar las fórmulas de energía de apilamiento entre vecinos próximos, el laboratorio interactivo ofrece dos controles fundamentales sobre la eficacia del bloqueo del empalme. El primer deslizador ajusta la energía libre de hibridación del dúplex, reflejando la fuerza con la que el oligonucleótido se une a su secuencia diana según la física de apareamiento de bases. Una unión más fuerte reduce la constante de disociación y desplaza el equilibrio frente al espliceosoma. El segundo control fija la concentración intranuclear de oligonucleótido libre, modelando la cantidad de cadenas terapéuticas en el núcleo. Examine las lecturas resultantes. La fracción de empalme canónico entre los exones 22 y 23 se aproxima al noventa por ciento conforme la inclusión del pseudoexón de 84 nucleótidos se desploma. Este cambio se traduce en la recuperación de más de la mitad del transporte de cloruro en células epiteliales. Por último, la actividad de escisión por RNasa H1 permanece en cero absoluto debido a las modificaciones químicas en los azúcares.
Riesgo Biofísico y Clínico: Los denominadores nacionales no combinados delimitan el contexto poblacional de los oligonucleótidos modificadores del empalme sin sumar cohortes entre fronteras ni equiparar inelegibilidad genotípica con eficacia clínica: CFFPR 2024 registra 92.3 % elegibles por genotipo, 26,277 de 29,314 (89.6 %) individuos elegibles con prescripción (3,037 o 10.4 % sin prescripción) y 8.0 % no elegibles; CCFR 2024 reporta 7.6 % no elegibles por edad y genotipo, 3,087 individuos en ETI (1,004 niños, 2,083 adultos) y 780 sin prescripción; UKCFR 2024 documenta 11,381 individuos totales (93 % de cobertura anual) y 8,830 asistentes a revisión en moduladores (80.3 % Kaftrio; 12.4 % sin uso previo); y ACFDR 2025 (31 dic 2025, sin trasplante) reporta 5.8 % no elegibles en adultos (2,326 con elegibilidad conocida) y 11.5 % (170 niños) en la cohorte pediátrica (1,473 niños). En 3849+10kb C->T, el candidato inhalado SPL84 figura bajo NCT06429176 (ClinicalTrials.gov does not evaluate safety or efficacy; listing on the registry does not denote government endorsement.), complementando los puentes `round202_class_vii_transcript_stability_bridge.py` y `nmd_evasion_model.py`.
Derivación Formal: La fuerza impulsora termodinámica que rige la hibridación del oligonucleótido antisentido con el pre-ARNm se formaliza mediante el modelo de vecinos próximos de Turner–Mathews: ΔG°_duplex = Σ ΔG°_NN(i, i+1) + ΔG°_init + ΔG°_sym + ΔG°_terminal_AU. Aquí, ΔG°_NN representa las energías libres de apilamiento en el dúplex de dieciocho a veintidós nucleótidos, mientras que ΔG°_init compensa la iniciación de la hélice y la repulsión electrostática. Las modificaciones químicas de 2'-O-metoxietilo (2'-MOE) en la ribosa fijan la conformación C3'-endo del azúcar, incrementando la estabilidad térmica entre 1.5 y 2.0 °C por residuo modificado y reduciendo la penalización entrópica. Asimismo, el esqueleto de fosforotioato confiere una marcada resistencia frente a exonucleasas nucleares, garantizando la persistencia metabólica en células epiteliales bronquiales. En el nucleoplasma, el oligonucleótido compite termodinámica y cinéticamente contra factores de empalme endógenos como U1 snRNP y SRSF1. La fracción de empalme canónico f_canon se rige por el equilibrio de la función de partición: f_canon = 1 / (1 + (K_d / [ASO]) exp(ΔG_cryptic / RT)), donde K_d = exp(ΔG°_duplex / RT) denota la constante microscópica de disociación y ΔG_cryptic caracteriza la ventaja intrínseca del donador críptico sobre la unión canónica. En el simulador (src/scripts/cftr-aso-splicing.js), cuando la concentración nuclear de ASO libre supera 50 nM y la estabilidad del dúplex sobrepasa −22 kcal/mol, la inclusión del pseudoexón cae por debajo del 15 %, restableciendo la unión canónica de los exones 22 y 23 sin activar degradación por RNasa H1.
Frontera Traslacional: Los límites traslacionales de los oligonucleótidos de bloqueo estérico están determinados por la topología de la secuencia y la maquinaria de empalme. El enmascaramiento es altamente eficaz en mutaciones de pseudoexones intrónicos profundos como 3849+10kb C>T y 1811+1.6kb A>G, donde la meta radica en ocultar un motivo aberrante para permitir el empalme canónico entre exones normales. En estos casos, la intervención produce proteína CFTR completamente silvestre, evitando defectos de plegamiento propios de los productos de lectura. Sin embargo, los oligonucleótidos antisentido no pueden reparar variantes que destruyen físicamente las uniones canónicas de consenso. Mutaciones en las posiciones invariables ±1 o ±2 de sitios donadores o aceptores—como 1717-1G>A en el intrón 11 o 621+1G>T en el intrón 4—anulan de forma definitiva motivos esenciales del espliceosoma. Enmascarar estas uniones no restituye el empalme normal porque la secuencia indispensable ya no existe en el ADN cromosómico. Estas variantes requieren edición de bases, edición de calidad o suplementación con ARNm. Además, mantener niveles terapéuticos en pulmón exige formulaciones en aerosol capaces de atravesar la densa barrera del moco sin causar inflamación crónica. Los modelos en organoides validan que los oligonucleótidos ofrecen un potencial terapéutico específico para mutaciones de pseudoexones, delimitando con precisión su lugar en la medicina génica y el ARN terapéutico.
Historial de ediciones (REV 1.3): REV 1.0 (2026-10-31): Publicación inicial: hibridación Turner de vecinos próximos y bloqueo estérico en 3849+10kb C>T. · REV 1.1 (2026-11-04): Se incorporó la función de partición competitiva frente a U1 snRNP y la destilación bilingüe. · REV 1.3 (2026-11-10): Se integraron denominadores nacionales no combinados (CFFPR 2024, CCFR 2024, UKCFR 2024, ACFDR 2025), los puentes Clase VII/NMD de Ronda 202 y el contexto NCT06429176 (SPL84) con aviso de NLM.
Horizonte terapéutico: Como los ASO son cadenas cortas (~6–7 kDa) químicamente estabilizadas que penetran en las células epiteliales tras su inhalación, constituyen una de las vías más directas de rescate genético. Investigación independiente, no asesoramiento médico.
Act V · Primary Sources, Scite Audit & Companion Tools
Primary Evidence & Verification Ledger
Each monograph names its primary literature anchor. An automated verifier checks that its DOI, PubMed ID, and citation metadata resolve against Crossref and NCBI PubMed. Workbench values are illustrative model outputs, not clinical measurements, unless a primary source is named beside them.
- Primary Literature Receipt: Michaels et al. (2020), Nucleic Acids Research 48(13):7454-7467 — Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells (PMID 32520327). (DOI 10.1093/nar/gkaa490 · PubMed 32520327 · PDB 6MSM).
- Citation Context (Scite): Inspect how later literature cites 10.1093/nar/gkaa490 on Scite.ai ·
Crossref + Scite verified (data/folio-citations.cache.json · fetched 2026-11-08 · 61 citing · 5 supporting · 58 mentioning · 0 contrasting). - Open-Source Computational & Epistemic Engine: Stim & PySCF Coupled-Cluster Nucleic Acid Energetics (DOI 10.22331/q-2021-07-06-497 · Scite Report).
- Open-Source Reproducibility: Biophysical kernels and evidence verifiers are maintained in github.com/senseiewok/cf-research and github.com/senseiewok/cf-skills.
For builders: method, companion SKILL.md, Python verifier, and edition history (REV 1.3)
cftr-aso-splice-switching-SKILL.md · Kernel src/scripts/cftr-aso-splicing.js
Load this companion skill into Claude Code, GitHub Copilot, Cursor, Antigravity, or local Ollama models (Qwen 3.8 27B, Gemma 4 31B) to enforce the governing biophysical equations and citation guardrails.
View raw SKILL.md source
--- name: cftr-aso-splice-switching description: AI-agnostic RNA therapeutics skill for steric-blocking 2'-MOE phosphorothioate ASOs, Turner nearest-neighbor hybridization thermodynamics, and CFTR cryptic splice rescue. license: CC-BY-4.0 --- # G.04 — Splice-Switching ASOs (3849+10kb C>T, 2789+5G>A) ## Governing Biophysical / Mathematical Law ΔG°_duplex = Σ ΔG°_NN(i, i+1) + ΔG°_init · f_canon = 1 / (1 + (K_d / [ASO]) exp(ΔG_cryptic / RT)) ## Primary Evidence Receipt - **Citation:** Michaels et al. (2020), Nucleic Acids Research 48(13):7454-7467 — Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells (PMID 32520327). - **DOI:** https://doi.org/10.1093/nar/gkaa490 - **PubMed PMID:** https://pubmed.ncbi.nlm.nih.gov/32520327/ - **Structural Reference (RCSB PDB):** https://www.rcsb.org/structure/6MSM - **Answer Tier:** T2 · Sourced RNA Splicing & Thermodynamic Model ## Verification Rules - Ensure splice-switching ASOs use full 2'-sugar modification (2'-MOE / 2'-OMe / PMO) with zero RNase H1 cleavage activity. - Distinguish deep-intronic pseudo-exon variants (3849+10kb C>T, 1811+1.6kb A>G) from invariant canonical ±1/±2 splice-site mutations (1717-1G>A). - Ground primary airway epithelial ASO splice rescue in Michaels et al. 2020 (DOI 10.1093/nar/gkaa490, PMID 32520327). ## Safety & Clinical Boundary Research synthesis and biophysical modeling only — never medical advice, clinical guidance, or a treatment promise.
Verified 5-Act magazine flow, untruncated headings, and bilingual EN / ES-MX structural parity.
Audited clinical dignity boundaries, non-promise guardrails, and discovery catalog coverage.
check_folio_citations.py
Verified DOI 10.1093/nar/gkaa490 against Crossref and NCBI PubMed metadata.
src/scripts/cftr-aso-splicing.js
Coupled governing relation ΔG°_duplex = Σ ΔG°_NN(i, i+1) + ΔG°_init · f to interactive Plates A & B.